2.65
                                            Schlusskurs vom Vortag:
              $2.66
            Offen:
              $2.66
            24-Stunden-Volumen:
                5,134
            Relative Volume:
              0.16
            Marktkapitalisierung:
                $14.36M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-16.35M
            KGV:
              -0.8689
            EPS:
                -3.05
            Netto-Cashflow:
                $-11.88M
            1W Leistung:
              -6.03%
            1M Leistung:
              -20.90%
            6M Leistung:
                -20.66%
            1J Leistung:
              -56.41%
            Lipocine Inc Stock (LPCN) Company Profile
Firmenname
                  
                      Lipocine Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      801 994 7383
                    
                Adresse
                  
                      675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
                    
                Vergleichen Sie LPCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                LPCN
                            
                             
                        Lipocine Inc 
                           | 
                    2.65 | 14.41M | 0 | -16.35M | -11.88M | -3.05 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2021-06-24 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2020-12-10 | Hochstufung | Ladenburg Thalmann | Neutral → Buy | 
| 2018-01-12 | Bestätigt | H.C. Wainwright | Buy | 
| 2018-01-11 | Herabstufung | Canaccord Genuity | Buy → Hold | 
| 2017-12-08 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2016-10-07 | Eingeleitet | H.C. Wainwright | Buy | 
| 2015-07-22 | Eingeleitet | ROTH Capital | Buy | 
| 2015-06-23 | Eingeleitet | Canaccord Genuity | Buy | 
                    Alle ansehen
                    
                  
                Lipocine Inc Aktie (LPCN) Neueste Nachrichten
How Lipocine Inc. stock reacts to inflationary pressures2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Will Lipocine Inc. stock go up soonGlobal Markets & Smart Swing Trading Alerts - newser.com
Lipocine Inc expected to post a loss of 54 cents a shareEarnings Preview - TradingView
Will Lipocine Inc. stock outperform value stocksMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
How Lipocine Inc. stock performs after earningsJuly 2025 Price Swings & Expert Verified Movement Alerts - newser.com
Why analysts upgrade Lipocine Inc. stockJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Is Lipocine Inc. stock a safe buy before earningsJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
Is Lipocine Inc. stock trading near support levelsEarnings Risk Report & Consistent Return Strategy Ideas - newser.com
How to build a dashboard for Lipocine Inc. stockEarnings Overview Report & Free Technical Pattern Based Buy Signals - newser.com
Smart tools for monitoring Lipocine Inc.’s price actionJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Will a bounce in Lipocine Inc. offer an exitMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.57 - Markets Mojo
Is Lipocine Inc. stock attractive for long term wealth buildingWeekly Market Summary & Momentum Based Trading Ideas - newser.com
What margin trends mean for Lipocine Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Is Lipocine Inc. stock dividend yield sustainableRecession Risk & Free Fast Entry Momentum Trade Alerts - Fundação Cultural do Pará
How risky is Lipocine Inc. stock now2025 Historical Comparison & Weekly Stock Performance Updates - fcp.pa.gov.br
Finanzdaten der Lipocine Inc-Aktie (LPCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):